Immunotherapy is not nearly as damaging as other therapies. In comparison to chemotherapy, immunotherapy kills only cancer cells, and not a whole region of healthy and cancerous cells. Chemotherapy also has a potential for second cancers to grow. The most common second cancer to come from chemotherapy are acute myelogenous leukemia and myelodysplastic syndrome. This is a dangerous route of therapy for children, as leukemia is the most common child cancer. Immunotherapy is used as a preventative from cancer recurring, and is less probable to second cancers. Immunotherapy is also not as hard on the body as radiation.